Goodwill and Other Intangible Assets, Net

3 Months Ended

Mar. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill

The changes in the carrying amount of goodwill by reporting unit for the three months ended March 31, 2017 were as follows (in thousands):



	Medical		Non- Medical		Total
December 30, 2016	$	950,326	$	17,000	$	967,326
Foreign currency translation	2,087		—		2,087
March 31, 2017	$	952,413	$	17,000	$	969,413

Intangible Assets

Intangible assets at March 31, 2017 and December 30, 2016 were as follows (in thousands):



	Gross Carrying Amount		Accumulated Amortization			Foreign Currency Translation			Net Carrying Amount
March 31, 2017
Definite-lived:
Purchased technology and patents	$	256,719	$	(104,977	)	$	794		$	152,536
Customer lists	759,987		(67,165		)	(4,202		)	688,620
Other	4,534		(5,171		)	788			151
Total	$	1,021,240	$	(177,313	)	$	(2,620	)	$	841,307
Indefinite-lived:
Trademarks and tradenames									$	90,288

December 30, 2016
Definite-lived:
Purchased technology and patents	$	256,719	$	(100,719	)	$	333		$	156,333
Customer lists	759,987		(60,474		)	(6,269		)	693,244
Other	4,534		(5,142		)	803			195
Total	$	1,021,240	$	(166,335	)	$	(5,133	)	$	849,772
Indefinite-lived:
Trademarks and tradenames									$	90,288

(5.) GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Continued)

Aggregate intangible asset amortization expense is comprised of the following (in thousands):



	Three Months Ended
	March 31, 2017		April 1, 2016
Cost of sales	$	4,084	$	4,240
Selling, general and administrative expenses	6,758		5,136
Research, development and engineering costs, net	136		88
Total intangible asset amortization expense	$	10,978	$	9,464

Estimated future intangible asset amortization expense based on the carrying value as of March 31, 2017 is as follows (in thousands):



	2017	2018	2019	2020	2021		After 2021
Amortization Expense	32,689	44,542	44,605	45,192	$	44,080	$	630,199

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details